Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT05146635
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (aged \>18 years)
* Patients with primary or recurrent papillary NMIBC.
* Complete TURBT.
* Patients with IR NMIBC confirmed by histopathology.
Exclusion Criteria:
* Inability to give informed consent.
* Patients with history of previous radiotherapy or systemic chemotherapy.
* Patients suffering from immuno-deficiency or other malignancies.
* Patients with history of hypersensitivity reaction to BCG or epirubicin.
* Examination under anesthesia (EUA) reveals palpable bladder mass.
* Patients with low or high risk NMIBC by histopathology
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05146635
Study Brief:
Protocol Section:
NCT05146635